Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Individualized Exercise Consultation in Type 1 Diabetes (ACTIVE-T1D)

5. juni 2026 opdateret af: University of Aarhus
People with type 1 diabetes often experience challenges managing blood glucose levels during and around physical activity, which may reduce participation in exercise. The ACTIVE-T1D project aims to evaluate whether individualized video-based exercise consultations can improve exercise-related confidence, physical activity levels, and glycemic management in adults with type 1 diabetes. Participants will receive individualized consultations focused on exercise, glucose management, insulin adjustment, and nutrition strategies related to physical activity. Consultations are tailored to the participant's exercise habits, goals, and challenges. The study will assess self-reported exercise management, physical activity, and glucose metrics obtained from continuous glucose monitoring systems. A subgroup of participants will also complete objective physical activity measurements using accelerometers. The study is conducted as a prospective quality improvement project at Steno Diabetes Center Aarhus.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Background Physical activity is a recommended and integral component of T1D treatment, as it confers a range of health benefits, including improved insulin sensitivity, better glycaemic regulation, enhanced cardiovascular fitness, healthier lipid profiles, weight management, reduced blood pressure, and a lower risk of diabetes-related complications (1). Additionally, regular exercise supports psychological well-being and overall quality of life for people living with type 1 diabetes (2). However, despite written guidelines on the topic (3), individuals with type 1 diabetes often experience challenges with blood glucose excursions before, during, and after exercise (4, 5), limiting participation in regular exercise.

In recognition of limited guidance for individuals with type 1 diabetes regarding exercise (6), the Clinic for Athletes with Type One Diabetes (CATOD) was established in 2019 at the Steno Diabetes Center Aarhus (SDCA). CATOD is the first clinic of its kind and has transformed care for individuals with type 1 diabetes who exercise. Initially, the clinic primarily supported highly active athletes with type 1 diabetes through sports camps followed by a 6-12 month consultation programme focused on exercise and diabetes management strategies(7).

Since 2023 the clinic has expanded to provide 1-3 videoconsultations to a broad range of individuals with type 1 diabetes across the nation in order to help them with exercise obstacles. The problems presented span from going for a walk or bicycling to work without getting a low blood glucose to how to manage glucose during marathon training and competition. During the consultations, the individual with type 1 diabetes receives individualized guidance on exercise, glucose management, insulin adjustment, and nutrition.

Evidence from a prior questionnaire administered to participants who received the intervention suggests that many benefited from the advice and were able to modify their exercise habits, facilitating more effective and less burdensome physical activity.

Aim This study aims to expand current knowledge on the effectiveness of individualized exercise consultations in people with type 1 diabetes. Specifically, we will evaluate whether individualized, video-based exercise consultations can improve physical activity levels, glycemic control and patient empowerment.

Objectives

To determine whether individualized, exercise-specific consultations:

  1. Increase physical activity levels
  2. Improve glycemic control during and around exercise, as well as overall glycemic control
  3. Enhance confidence and self-management related to exercise

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

60

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

  • Navn: Jesper F Mortensen, MSc
  • Telefonnummer: +45 23234145
  • E-mail: jfm@au.dk

Studiesteder

  • Danmark
      • Aarhus, Danmark, 8200
        • Steno Diabetes Center Aarhus
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Diagnosis of type 1 diabetes
  • Age ≥18 years
  • Willingness to participate

Exclusion Criteria:

  • None

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Exercise Consultations
Andet: Exercise consultations

Participants will receive individualized 30-minute video consultations concerning exercise and type 1 diabetes obstacles. During the consultations, individuals with type 1 diabetes are guided by a physician and, when relevant, an exercise physiologist from Steno Diabetes Center Aarhus (SDCA).

The intervention will in most cases consist of two consultations, although an additional consultation may be offered if considered relevant.

The first consultation is planned based on information about the individual's exercise habits and specific challenges. All consultations are conducted via video, allowing participants to receive tailored, practical advice adapted to their daily life and preferred physical activities. Consultations will address the topics that the patient presents, which may include, but is not limited to:

  • Exercise habits and goals
  • The need for advice concerning insulin adjustments
  • The need for advice concerning carbohydrate strategies

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Diabetes and Exercise Self-Management Ability Score, assessed using eight Likert-scale questions regarding the participant's perceived ability to manage type 1 diabetes and exercise-related challenges.
Tidsramme: Eight months
Each item is scored on a 5-point Likert scale: 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, and 5 = strongly agree. The total score ranges from 8 to 40, with higher scores indicating greater perceived ability to manage type 1 diabetes during exercise. The score is assessed before the first consultation, immediately after the final consultation, and 6 months after the final consultation.
Eight months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

University of Aarhus

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. juni 2026

Primær færdiggørelse (Anslået)

1. december 2027

Studieafslutning (Anslået)

1. juni 2028

Datoer for studieregistrering

Først indsendt

12. maj 2026

Først indsendt, der opfyldte QC-kriterier

12. maj 2026

Først opslået (Faktiske)

19. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

9. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

5. juni 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 1-20-72-8-26

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Type 1 diabetes

Kliniske forsøg med Exercise consultations

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Angola

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner